デフォルト表紙
市場調査レポート
商品コード
1373878

コンパニオンアニマルヘルスケアの世界市場 (2023-2030年):タイプ (医薬品・ワクチン)・用途 (動物病院・動物クリニック) 別の規模・シェア・成長分析・予測

Global Companion Animal Healthcare Market Size, Share, Growth Analysis, By Type(Pharmaceuticals, Vaccines), By Application(Veterinary Hospitals, Veterinary Clinics) - Industry Forecast 2023-2030

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
コンパニオンアニマルヘルスケアの世界市場 (2023-2030年):タイプ (医薬品・ワクチン)・用途 (動物病院・動物クリニック) 別の規模・シェア・成長分析・予測
出版日: 2023年10月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のコンパニオンアニマルヘルスケアの市場規模は、2021年の215億米ドル、予測期間中は8.4%のCAGRで推移し、2022年の233億1,000万米ドルから2030年には444億3,000万米ドルに成長する見通しです。

コンパニオンアニマルヘルスケアの市場は近年、著しい成長を遂げています。犬、猫、馬を含むコンパニオンアニマルは、世界の何百万人もの人々の生活に不可欠な役割を果たしており、彼らの健康のための高品質なヘルスケア製品およびサービスへの需要が高まっています。ペットを家族の一員と考える人が増えるにつれ、高度な獣医療、予防薬、治療法に対する需要が急増しています。ペットの飼い主は現在、定期検診、ワクチン接種、専門的治療などの獣医学的サービスに積極的に出費するようになり、コンパニオンアニマルヘルスケア製品の需要を押し上げています。ペットの飼い主は、動物の全体的な健康をより意識するようになり、予防的ヘルスケアが重視されるようになっています。このため、ワクチン、ノミ・ダニ駆除剤、栄養補助食品などの需要が急増しています。さらに、獣医学的診断の進歩と革新的な製品のアベイラビリティにより、病気の早期発見が容易になり、治療成績が向上しています。

一方で、特定の地域では、動物病院や専門家の不足により、コンパニオンアニマルヘルスケアサービスの利用が制限されています。不十分な獣医学的インフラは、コンパニオンアニマルにヘルスケアサービスを提供する上での課題となっており、市場成長を妨げる可能性があります。また、スキルを有する人材や診療所の不足もヘルスケアの選択肢を制限し、市場の拡大を妨げています。

当レポートでは、世界のコンパニオンアニマルヘルスケアの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

  • エグゼクティブサマリー
  • 調査手法
  • 親市場の分析
    • 市場概要
    • 市場規模
    • 市場力学
      • 促進要因
      • 機会
      • 抑制要因
      • 課題
  • 主要な市場洞察
    • 技術分析
    • 価格分析
    • サプライチェーン分析
    • バリューチェーン分析
    • 市場のエコシステム
    • IP分析
    • 貿易分析
    • スタートアップ分析
    • 原材料分析
    • イノベーションマトリックス
    • パイプライン製品の分析
    • マクロ経済指標
    • 主要投資分析
    • 主要な成功要因
    • 競合の程度
    • 市場力学と見通し
      • 市場力学
        • 促進要因
        • 機会
        • 抑制要因
        • 課題
    • 規制状況
    • ポーターの分析
    • 将来のディスラプションに関するSkyquestの特別な洞察
  • 世界のコンパニオンアニマルヘルスケア市場:タイプ別
    • 市場概要
    • 医薬品
    • ワクチン
    • 飼料添加物
    • 診断・その他
  • 世界のコンパニオンアニマルヘルスケア市場:用途別
    • 市場概要
    • 動物病院
    • 動物クリニック
    • 薬局・ドラッグストア
    • オンライン薬局・その他
  • 世界のコンパニオンアニマルヘルスケア市場:地域別
    • 市場概要
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 競合情勢
    • トップ5社の比較
    • 主要企業の市場での位置付け
    • 主要企業の採用戦略
    • 主要成功戦略
    • 市場における最近の活動
    • 主要企業の市場シェア
  • 主要企業プロファイル
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim GmbH
    • Bayer AG
    • Virbac
    • Ceva Sante Animale
    • Vetoquinol S.A.
    • IDEXX Laboratories, Inc.
    • Dechra Pharmaceuticals PLC
    • Norbrook Holdings Limited
    • Kindred Biosciences, Inc.
    • Heska Corporation
    • Phibro Animal Health Corporation
    • Nutramax Laboratories Veterinary Sciences, Inc.
    • Merial (Sanofi S.A.)
    • Neogen Corporation
    • PetIQ, Inc.
    • AniCura AB
    • VCA Inc.
目次
Product Code: SQMIG35E2026

Global Companion Animal Healthcare Market size was valued at USD 21.5 billion in 2021 and is poised to grow from USD 23.31 billion 2022 to USD 44.43 billion by 2030, growing at a CAGR of 8.4% during the forecast period (2023-2030).

The global companion animal healthcare market has experienced significant growth in recent years. Companion animals, including dogs, cats, and horses, play an integral role in the lives of millions of people worldwide, leading to a rise in demand for high-quality healthcare products and services for their well-being. As more people consider their pets as family members, the demand for advanced veterinary care, preventive medications, and therapeutic treatments has surged. Pet owners are now more willing to spend on veterinary services, including routine check-ups, vaccinations, and specialized treatments, thereby boosting the demand for companion animal healthcare products. Pet owners are becoming more conscious about the overall well-being of their animals, leading to an increased emphasis on preventive healthcare measures. This has led to a surge in the demand for products such as vaccines, flea and tick control treatments, and nutritional supplements. Furthermore, advancements in veterinary diagnostics and the availability of innovative products have facilitated early disease detection and improved treatment outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Companion Animal Healthcare Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Healthcare Market Segmental Analysis

The Global Companion Animal Healthcare Market is segmented by type, application, and region. Based on type, the market can be segmented into Pharmaceuticals, Vaccines, Feed Additives, Diagnostics and Others. Based on application, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Companion Animal Healthcare Market

Human-Animal Bond and Emotional Well-being

The deep emotional connection between humans and their companion animals is a key driver for the demand in high-quality healthcare services. Pet owners prioritize the well-being of their animals and are willing to invest in specialized care, medications, and supplements to ensure their pets' longevity and enhance their overall quality of life. This emotional bond fuels the growth of the companion animal healthcare market as pet owners seek comprehensive healthcare solutions.

Restraints in the Global Companion Animal Healthcare Market

Lack of Veterinary Infrastructure

In certain regions, the availability and accessibility of companion animal healthcare services are limited due to a shortage of veterinary clinics and professionals. The inadequate veterinary infrastructure hampers the market's growth potential as it creates challenges in delivering healthcare services to companion animals. The scarcity of skilled personnel and clinics restricts the availability of healthcare options, hindering the market's expansion in those regions.

Market Trends of Global Companion Animal Healthcare Key

A key market trend in the global companion animal healthcare market is the growing focus on preventive healthcare for pets. Pet owners are increasingly recognizing the importance of maintaining their companion animals' overall health and well-being, rather than solely addressing illness or disease. This shift in mindset has led to a rise in the demand for preventive healthcare products and services, including vaccinations, regular check-ups, parasite control, and nutritional supplements for pets.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Companion Animal Healthcare Market by Type
    • Market Overview
    • Pharmaceuticals
    • Vaccines
    • Feed Additives
    • Diagnostics and Others.
  • Global Companion Animal Healthcare Market by Application
    • Market Overview
    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies & Drug Stores
    • Online Pharmacies and Others.
  • Global Companion Animal Healthcare Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Zoetis Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Elanco Animal Health Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dechra Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Norbrook Holdings Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Kindred Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Phibro Animal Health Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nutramax Laboratories Veterinary Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merial (Sanofi S.A.) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • PetIQ, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AniCura AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • VCA Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

1.